ViiV Healthcare and J&J’s adolescent HIV-1 combo gains EC authorisation
The EC has authorised the use of ViiV Healthcare’s Vocabria plus Rekambys from J&J for treating adolescents with HIV-1.
The EC has authorised the use of ViiV Healthcare’s Vocabria plus Rekambys from J&J for treating adolescents with HIV-1.
What's Your Reaction?
